BioAge seeks nearly $200 million in initial public offering
September 27, 2024 at 07:06 AM EDT
The company is concentrating its aging diseases focus on weight loss and diabetes control.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.